HomeCMMB • NASDAQ
add
Chemomab Therapeutics Ltd - ADR
Previous close
$2.62
Day range
$2.50 - $2.67
Year range
$2.36 - $9.84
Market cap
15.51M USD
Avg Volume
106.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.84M | -50.30% |
Net income | -1.74M | 49.99% |
Net profit margin | — | — |
Earnings per share | -0.00 | 90.00% |
EBITDA | -1.83M | 50.43% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.06M | -48.11% |
Total assets | 12.37M | -40.81% |
Total liabilities | 1.14M | -75.17% |
Total equity | 11.23M | — |
Shares outstanding | 6.16M | — |
Price to book | 1.44 | — |
Return on assets | -39.24% | — |
Return on capital | -44.05% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.74M | 49.99% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2011
Website
Employees
16
